Unlike T cells, the cytotoxicity of NK cells is not limited by the target cell’s expression of molecules of the major histocompatibility complex (MHC), thus providing broader tumor recognition, avoiding the risk of graft-versus-host disease (GVHD), and allowing these cells to be used in allogeneic settings. Here, HLA-C is linked to graft versus host disease.